
Novalitha Pharma Private Limited
Founded in 2018 and headquartered in Telangana, India.
Founded in 2018 and headquartered in Telangana, India.
Novalitha Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and five months 11 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.70 M.
Surya Easarla and Veera Easarla serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
-
U24303TG2018PTC126911
126911
Private Limited Indian Non-Government Company
20 Sep 2018
30 Sep 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Surya Easarla ![]() | Managing Director | 20-Sep-2018 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Veera Easarla ![]() | Director | 20-Sep-2018 | Current |
Novalitha Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.68% increase. The company also saw a substantial improvement in profitability, with a 42.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 84.28%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Novalitha Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹2.70 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
02 Mar 2020 | Others | ₹2.70 M | Open |
Unlock and access historical data on people associated with Novalitha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novalitha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalitha Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Novalitha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023
Novalitha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023
A charge with Others amounted to Rs. 2.70 M with Charge ID 100333517 was registered on 02 Mar 2020.
02 Mar 2020
Surya Rao Easarla was appointed as a Managing Director was appointed as a Managing Director on 20 Sep 2018 & has been associated with this company since 6 years 5 months .
20 Sep 2018
Veera Venkata Ramana Easarla was appointed as a Director was appointed as a Director on 20 Sep 2018 & has been associated with this company since 6 years 5 months .
20 Sep 2018
Novalitha Pharma Private Limited was registered on 20 Sep 2018 with Roc Hyderabad & aged 6 years 5 months as per MCA records.
20 Sep 2018
Novalitha Pharma Private Limited was incorporated on 20 Sep 2018.
The authorized share capital of Novalitha Pharma Private Limited is ₹ 4.00 M and paid-up capital is ₹ 4.00 M.
Currently 2 directors are associated with Novalitha Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Novalitha Pharma Private Limited is F-301 7-2-1735 And 1813/5/A 3Rd Floor Sopanam Enclave Czech Colony, Sanath Na Gar India, Hyderabad, Telangana, 500018.
The corporate identification number (CIN) of Novalitha Pharma Private Limited is U24303TG2018PTC126911 and the company number is 126911 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Novalitha Pharma Private Limited has risen by 65.68%.
The financial reports for the fiscal year 2022 indicates that The net worth of Novalitha Pharma Private Limited has experienced an downturn of -84.28%.
As per the financial statements for fiscal Year 2022, The total open charges for Novalitha Pharma Private Limited amount to ₹ 2.70 M.
The most recent Balance Sheet for Novalitha Pharma Private Limited was filed with the ROC on 31 Mar 2023.